MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/medicina60111801

Медицинская библиотека · Medicina (Kaunas, Lithuania) · 2024

The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes.

Baba Dragos-Florin, Suciu Horatiu, Avram Calin, Harpa Marius Mihai, Stoian Mircea, Moldovan Diana-Andreea, Huma Laurentiu, Rusu Gabriel, Pal Tunde, Danilesco Alina, Stoian Adina, Sin Anca-Ileana

СтатьяПеревод в очереди

Аннотация

Background and

Objectives

Cardiac transplantation represents the option for patients with end-stage heart failure (HF), providing the best survival rate. However, the postoperative complications of transplant patients remain a challenge for clinicians. The objective of our study was to evaluate the effect of preoperative chronic HF treatment on the occurrence of in-hospital complications. Materials and

Methods

We retrospectively included a total of 50 patients who underwent cardiac transplantation between January 2011 and December 2023 from the Emergency Institute for Cardiovascular Diseases and Transplantation of Targu Mures. We correlated the preoperative chronic HF treatment with the postoperative complications by Spearmen's correlation coefficient, respectively. With logistic regression, the associations between the treatment and specific complications were determined.

Results

Significant negative correlations were found between Carvedilol treatment with 2-month mortality (r = -0.30; 95% CI: -0.53--0.02; p = 0.03), Ramipril with hospital stay (r = -0.38; 95% CI: -0.60--0.12; p < 0.01) and intensive care unit (ICU) stay (r = -0.37; 95% CI: -0.59--0.11; p = 0.01), and Spironolactone usage with hospitalization duration (r = -0.28; 95% CI: -0.52--0.01; p = 0.04). Furthermore, Carvedilol treatment represented a protective factor against early acute kidney injury (AKI) (OR: 0.22; 95% CI: 0.05-0.91; p = 0.03). Spironolactone treatment was a protective factor against AGR (OR: 0.12; 95% CI: 0.02-0.66; p = 0.01) treatment, in contrast to angiotensin-converting enzyme inhibitor (ACEI) therapy (OR: 5.30; 95% CI: 1.03-27.17; p = 0.04).

Conclusions

Pre-transplant Carvedilol treatment was negatively correlated with the 2-month mortality rate. Ramipril and Spironolactone therapy were negatively correlated with hospitalization duration, and Ramipril was additionally correlated with ICU stay. Moreover, Carvedilol therapy represented a protective factor against early AKI. Pre-transplant Spironolactone was associated with lower event rates of AGR, in contrast to ACEI treatment. Prospective studies with larger cohorts are needed in order to draw drastic conclusions.

Для цитирования: Baba Dragos-Florin, Suciu Horatiu, Avram Calin, Harpa Marius Mihai, Stoian Mircea, Moldovan Diana-Andreea, Huma Laurentiu, Rusu Gabriel, Pal Tunde, Danilesco Alina, Stoian Adina, Sin Anca-Ileana. The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes.. Medicina (Kaunas, Lithuania). 2024. DOI: 10.3390/medicina60111801.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.